• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Zantac (ranitidine hydrochloride)

  • Zantac (ranitidine hydrochloride) 150/300 tablets
  • Zantac (ranitidine hydrochloride) 25/150 EFFERdose tablets  
  • Zantac (ranitidine hydrochloride effervescent) 150 granules
  • Zantac (ranitidine hydrochloride) injection and bulk injection Pharmacy Pack
  • Zantac (ranitidine hydrochloride) Premixed injection 
  • Zantac (ranitidine hydrochloride) Syrup

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- September 2009

 

Summary View

 

ADVERSE REACTIONS

Endocrine
  • Controlled studies in animals and man have shown no stimulation of any pituitary hormone by Zantac and no antiandrogenic activity...